 The purpose of this study is to determine the safety, tolerability, pharmacokinetics and pharmacodynamics how the drug effects certain target sites of activity in the body of escalating doses of oral PF-04171327 in healthy volunteers for 14 days Part 1. Part 2 will evaluate the pharmacokinetics of a single 10 mg dose of the PF-04171327 tablet in healthy volunteers. 